Recommended Topic Related To:

Cosopt

"Jan. 4, 2013 -- A new study from Australia may offer a new way of identifying people at risk of glaucoma years before vision loss happens.

Glaucoma is a leading cause of blindness. But because vision damage often occurs gradually, mos"...

Cosopt

OVERDOSE

There are no human data available on overdosage with COSOPT (dorzolamide hydrochloride-timolol maleate ophthalmic solution) .

Symptoms consistent with systemic administration of beta-blockers or carbonic anhydrase inhibitors may occur, including electrolyte imbalance, development of an acidotic state, dizziness, headache, shortness of breath, bradycardia, bronchospasm, cardiac arrest and possible central nervous system effects. Serum electrolyte levels (particularly potassium) and blood pH levels should be monitored (see also ADVERSE REACTIONS).

A study of patients with renal failure showed that timolol did not dialyze readily.

CONTRAINDICATIONS

COSOPT (dorzolamide hydrochloride-timolol maleate ophthalmic solution) is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease (see WARNINGS); (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure (see WARNINGS); (7) cardiogenic shock; or (8) hypersensitivity to any component of this product.

Last reviewed on RxList: 7/20/2010
This monograph has been modified to include the generic and brand name in many instances.

A A A

Cosopt - User Reviews

Cosopt User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Cosopt sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.